Skip to main content

HHSC Removed Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines from Formulary

Last updated on

On April 21, 2023, the Texas Health and Human Services Commission (HHSC) removed the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines from the drug formulary as a result of the announcement by the U.S. Food and Drug Administration (FDA). The following vaccines will be removed:

National Drug Code

Label Name

Generic Name

59267100001

Pfizer COVID-19 vaccine-purple

COVID-19 vacc, mRNA(Pfizer)/PF

59267100002

Pfizer COVID-19 vaccine-purple

COVID-19 vacc, mRNA(Pfizer)/PF

59267100003

Pfizer COVID-19 vaccine-purple

COVID-19 vacc, mRNA(Pfizer)/PF

80777027310

Moderna COVID-19(12y up)vac(eua)

COVID-19 vacc,mRNA(Moderna)/PF

80777027315

Moderna COVID-19(12yup)vac(eua)

COVID-19 vacc,mRNA(Moderna)/PF

80777027398

Moderna COVID-19(12yup)vac(eua)

COVID-19 vacc,mRNA(Moderna)/PF

80777027399

Moderna COVID-19(12yup)vac(eua)

COVID-19 vacc,mRNA(Moderna)/PF

80777027705

Moderna COVID-19(6-11y)vacc(eua)

COVID-19 vacc,pedi(Moderna)/PF

80777027799

Moderna COVID-19(6-11y)vacc(eua)

COVID-19 vacc,pedi(Moderna)/PF

80777027905

Moderna COVID-19(6m-5y)vacc(eua)

COVID-19 vacc,pedi (Moderna)/PF

80777027999

Moderna COVID-19(6m-5y)vacc(eua)

COVID-19 vacc,pedi (Moderna)/PF

Important: This announcement by the FDA also includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) for all doses administered to individuals 6 months or older, including for an additional dose or doses for certain populations.

Contact vdp-formulary@hhsc.state.tx.us with comments or questions.